2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Eberhardt, W.E.; De Ruysscher, D.; Weder, W.; Le Péchoux, C.; De Leyn, P.; Hoffmann, H.; Westeel, V.; Stahel, R.; Felip, E.; Peters, S.

doi:10.1093/annonc/mdv187

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Details

Download: REF.pdf (294.88 [Ko])
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.

Serval ID

serval:BIB_EFBB910B02B7

Type

Article: article from journal or magazin.

Publication sub-type

Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.

Collection

Publications

Institution

UNIL/CHUV

Title

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Journal

Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo

Author(s)

Eberhardt W.E., De Ruysscher D., Weder W., Le Péchoux C., De Leyn P., Hoffmann H., Westeel V., Stahel R., Felip E., Peters S.

Working group(s)

Panel Members

Contributor(s)

Stahel R., Felip E., Peters S., Kerr K., Besse B., Vansteenkiste J., Eberhardt W., Edelman M., Mok T., O'Byrne K., Novello S., Bubendorf L., Marchetti A., Baas P., Reck M., Syrigos K., Paz-Ares L., Smit EF., Meldgaard P., Adjei A., Nicolson M., Crinó L., Van Schil P., Senan S., Faivre-Finn C., Rocco G., Veronesi G., Douillard JY., Lim E., Dooms C., Weder W., De Ruysscher D., Le Pechoux C., De Leyn P., Westeel V.

ISSN

1569-8041 (Electronic)

ISSN-L

0923-7534

Publication state

Published

Issued date

2015

Peer-reviewed

Oui

Volume

Number

Pages

1573-1588

Language

english

Notes

Publication types: Consensus Development Conference ; Journal Article ; Practice Guideline ; Review
Publication Status: ppublish

Abstract

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on locally advanced disease.

Keywords

Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bronchoscopy, Carboplatin/administration & dosage, Carcinoma, Non-Small-Cell Lung/diagnosis, Carcinoma, Non-Small-Cell Lung/pathology, Chemotherapy, Adjuvant, Cisplatin/administration & dosage, Disease Management, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Etoposide/administration & dosage, Europe, Humans, Lung/pathology, Lung/radiography, Lung Neoplasms/diagnosis, Lung Neoplasms/pathology, Lymph Nodes/pathology, Mediastinum, Multimodal Imaging, Pneumonectomy, Positron-Emission Tomography, Radiotherapy, Adjuvant, Societies, Medical, Tomography, X-Ray Computed, Vinblastine/administration & dosage, Vinblastine/analogs & derivatives

URN

urn:nbn:ch:serval-BIB_EFBB910B02B71

OAI-PMH

oai:serval.unil.ch:BIB_EFBB910B02B7

DOI

10.1093/annonc/mdv187

Pubmed

25897013

Web of science

000359312100010

Open Access

Yes